lancet-header
Preprints with The Lancet is part of SSRN´s First Look, a place where journals and other research experts identify content of interest prior to publication. These preprint papers are not peer-reviewed. Authors have either opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet, or submitted directly via SSRN. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. These papers should not be used for clinical decision making or reporting of research to a lay audience without indicating that this is preliminary research that has not been peer-reviewed. For more information see the Comment published in The Lancet, or visit The Lancet´s FAQ page, and for any feedback please contact preprints@lancet.com

Estimating Instant Fatality Rate of COVID-19 in China

36 Pages Posted: 31 Mar 2020

See all articles by Yan-ni Mi

Yan-ni Mi

Xi'an Jiaotong University (XJTU) - School of Basic Medical Sciences

Ting-ting Huang

Xi'an Jiaotong University (XJTU) - School of Basic Medical Sciences

Jun-xia Zhang

Xi'an Jiaotong University (XJTU) - School of Basic Medical Sciences

Qi Qin

Xi'an Jiaotong University (XJTU) - School of Basic Medical Sciences

Ya-xin Gong

Xi'an Jiaotong University (XJTU) - School of Basic Medical Sciences

Si-yu Liu

Xi'an Jiaotong University (XJTU) - School of Basic Medical Sciences

Hui-min Xue

Xi'an Jiaotong University (XJTU) - School of Basic Medical Sciences

Chang-hua Ning

Xi'an Jiaotong University (XJTU) - School of Basic Medical Sciences

Lei Cao

Xi'an Jiaotong University (XJTU) - Department of Pharmacology

Yong-xiao Cao

Xi'an Jiaotong University (XJTU) - Department of Pharmacology

More...

Abstract

Background: The outbreak of the coronavirus disease 2019 (COVID-19) in China has been basically controlled. However, the worldwide COVID-19 cases are increasing rapidly, showing a trend of global outbreak. Case fatality rate is the most direct indicator to assess the hazards of an infectious disease. We aimed to estimate the instant case fatality rate and cure rate of COVID-19 in China.

Methods: We collected the accumulated data such as the numbers of daily confirmed/deaths/cured cases and the number of daily cumulative confirmed/deaths/cured cases released officially by Chinese authority from Dec 8, 2019 to Mar 15, 2020. Basing on the dates of diagnosis, deaths and discharge from individual cases, death time and cure time were calculated. And then the estimated diagnosis date of deaths and cured cases in the daily case notification data were calculated based on median cure time or median death time. Afterwards, according to the numbers of deaths and cured cases on the same estimated diagnosis dates the instant fatality rate was calculated.

Findings: We collected 80860 confirmed cases of COVID-19, 13062 cases of them came from China except Hubei. In China the instant case fatality rate of COVID-19 was less than 10% (3.7-9.96%) from Jan 1 to Jan 15, 2020, continuously increased to 12% on Jan 19, and then gradually declined and stabilized at 4.4% on Feb 29. The instant case fatality rate tended to be stable at the end of February. The plateau was estimated at 4.2% at the end of March. The average case fatality rate in China was 7.4±3.1%%. In China except Hubei the case fatality rate was 0.5% to 3.4% from Feb 15 to Feb 29. Whereafter, the case fatality rate tended to be stable and less than 1%. The average case fatality rate was 1.1±0.6%. The instant cure rates of COVID-19 were 92.6%±3.1% in China, and the estimated one was 95.8%, while it was 98.9%±0.6% in China except Hubei.

Interpretation: The instant case fatality rate of COVID-19 in China was much higher than that in China except Hubei. The instant cure rate in China except Hubei was higher than that in China. The fatality rate of COVID-19 in China was underestimated.

Funding Statement: National Natural Science Foundation of China (No. 81803647and No. 81670001).

Declaration of Interests: The authors declare no competing interests.

Keywords: COVID-19; fatality rate; cure rate; China

Suggested Citation

Mi, Yan-ni and Huang, Ting-ting and Zhang, Jun-xia and Qin, Qi and Gong, Ya-xin and Liu, Si-yu and Xue, Hui-min and Ning, Chang-hua and Cao, Lei and Cao, Yong-xiao, Estimating Instant Fatality Rate of COVID-19 in China (3/16/2020). Available at SSRN: https://ssrn.com/abstract=3557980 or http://dx.doi.org/10.2139/ssrn.3557980

Yan-ni Mi

Xi'an Jiaotong University (XJTU) - School of Basic Medical Sciences

China

Ting-ting Huang

Xi'an Jiaotong University (XJTU) - School of Basic Medical Sciences

China

Jun-xia Zhang

Xi'an Jiaotong University (XJTU) - School of Basic Medical Sciences

China

Qi Qin

Xi'an Jiaotong University (XJTU) - School of Basic Medical Sciences

China

Ya-xin Gong

Xi'an Jiaotong University (XJTU) - School of Basic Medical Sciences

China

Si-yu Liu

Xi'an Jiaotong University (XJTU) - School of Basic Medical Sciences

China

Hui-min Xue

Xi'an Jiaotong University (XJTU) - School of Basic Medical Sciences

China

Chang-hua Ning

Xi'an Jiaotong University (XJTU) - School of Basic Medical Sciences

China

Lei Cao (Contact Author)

Xi'an Jiaotong University (XJTU) - Department of Pharmacology ( email )

Xi’an, 710061
China

Yong-xiao Cao

Xi'an Jiaotong University (XJTU) - Department of Pharmacology ( email )

Xi’an, 710061
China

Click here to go to TheLancet.com

Paper statistics

Abstract Views
516
Downloads
39